ata bta tinnitus partnership

American Tinnitus Association and British Tinnitus Association Partner to Advocate for Increased Tinnitus Research

VIENNA, VIRGINIA — The American Tinnitus Association (ATA) and British Tinnitus Association (BTA) are have announced a partnership to advocate for increased tinnitus research that offers progress for patients worldwide.  “Progress in tinnitus research depends upon new insights, and we believe that new alliances among scientists engaged in various aspects of auditory science can spark these insights. The…

Read More
hearing aid bill senate

Senator Introduces Bill to Improve US Veterans Access to Hearing Care

WASHINGTON, D.C. — With Veterans Day around the corner, U.S. Senator Tina Smith (D-Minn.) introduced legislation to reduce the red tape many veterans face when trying to get care for hearing loss as a result of their service—something many veterans say is an enormous burden despite being the most common service-connected ailment. Sen. Smith heard…

Read More
auris medical tinnitus drug

Auris Medical Forms Scientific Advisory Board for Tinnitus Programs

HAMILTON, BERMUDA — Biopharmaceutical company Auris Medical Holdings has announced the formation of a Scientific Advisory Board (SAB) for its tinnitus research and development programs. “We are delighted to have several world-renowned tinnitus experts join Auris Medical as advisors as we are preparing to advance our various tinnitus projects through further clinical and pre-clinical development.…

Read More
american tinnitus association

American Tinnitus Association Announces Election of New Board Chair and Vice-Chair

VIENNA, VIRGINIA — The American Tinnitus Association (ATA) Board of Directors has elected Dr. Jill Meltzer as Chair and John Minnebo as Vice-Chair for two-year terms.    ATA is a national nonprofit organization committed to improving the lives of the approximately 25 million people in the United States who live with tinnitus, or ringing in…

Read More
tinnitus clinical trial otonomy

Otonomy Initiates Phase 1/2 Clinical Trial of OTO-313 for Tinnitus

SAN DIEGO, CALIFORNIA — Otonomy has announced the initiation of a Phase 1/2 clinical trial of OTO-313 in patients with tinnitus. The randomized, double-blind, placebo-controlled Phase 1/2 study will include an initial safety cohort followed by an exploratory efficacy study that will enroll approximately 50 patients with subjective tinnitus. OTO-313 is said to be a…

Read More
combat earplugs lawsuit

Legal Update: Defective Earplugs and 3M Lawsuit

Editor’s Note: Today’s post comes from guest contributor, and consumer advocate, Joseph Oot The 3M Company is reportedly facing legal issues once again over their dual-ended Combat Arms Earplugs, Version 2 (CAEv2), as veterans and military members across the country are filing lawsuits. In May 2016, Moldex-Metric filed a lawsuit against 3M on behalf of…

Read More
tinnitus relief cbt therapy

Cognitive Behavioral Therapy for Tinnitus Relief: New Findings from Research Hold Promise for Patients and Providers

Although considered a prevalent condition, tinnitus remains a challenging condition for hearing care professionals to treat and manage. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. Experts believe that about one in five individuals who experience tinnitus are bothered…

Read More
tinnitus relief white noise study

White Noise Therapy for Tinnitus Relief Should be Avoided, Says JAMA Study

Tinnitus is a widespread problem with approximately 20 million Americans suffering from bothersome reactions to it. Although there are a few scientifically-validated therapies for many types of tinnitus, many patients are apt to try various types of over-the-counter solutions, including products with white noise masking. An August 30 JAMA-Otolaryngology report indicates white noise therapy for…

Read More
tinnitus neuromodulation treatment

Invasive Nature of Some Tinnitus Treatments Not a Deterrent for Many

Tinnitus is a highly prevalent condition with approximately 10%–15% of the population reporting the condition, and 1% to 2% of this group reporting burdensome tinnitus that leads to a severe decrease in the quality of life. Another consideration: tinnitus-related health care expenditures, which are mainly incurred out-of-pocket, are estimated to be nearly $2,000 per year…

Read More
auris medical tinnitus drug trial

Auris Medical Announces Disappointing Results from Tinnitus Drug Trial; Company Stock Price Plummets

ZUG, SWITZERLAND — Biopharmaceutical company Auris Medical Holdings announced disappointing results from its TACTT3 clinical trial for its promising tinnitus drug candidate, Keyzilen.  Preliminary top-line data from the trial indicate that the study did not provide a statistically significant improvement in the Tinnitus Functional Score from baseline to Day 84 in the active treated group compared…

Read More